 Hepatocellular carcinoma Italian patients cirrhosis BACKGROUND AND METHODS Patients cirrhosis liver risk hepatocellular carcinoma magnitude risk natural history disease possibilities curable tumors patients Western world unknown questions Italian patients well-compensated cirrhosis viral origin percent serum alpha-fetoprotein assays real-time ultrasonography months RESULTS Hepatocellular carcinoma patients percent base line patients percent patients free tumor base line follow-up periods months range cumulative hazard development hepatocellular carcinoma follow-up patients serum alpha-fetoprotein levels tumors levels fluctuating levels normal levels patients operable tumors proportion operable tumors follow-up proportion enrollment survival year patients surgery percent tumor-recurrence rate percent Outcome different patients surgery CONCLUSIONS West Asia patients cirrhosis liver substantial risk hepatocellular carcinoma yearly incidence rate percent program rate detection curable tumors